Astronaut Sophie Adenot demonstrated a technology system on the International Space Station that produces medical-grade intravenous fluids from potable water [1].
This development addresses a critical logistics challenge for long-duration spaceflight. Because IV fluids are heavy and bulky to transport, the ability to generate them in orbit reduces the frequency and cost of cargo missions required to maintain medical supplies.
The demonstration, titled "Intravenous Fluid Generation – Mini," took place on mission day 91 [1]. During orbit 1,410, Adenot set up and operated the equipment to verify its ability to convert the station's water supply into saline solutions [1].
"Day 091, orbit 1410 — In this timelapse, I’m first setting up and then carrying out a technology demonstration called Intravenous Fluid Generation – Mini," Adenot said [1].
The system is designed to ensure a sustainable supply of IV fluids, which are essential for treating dehydration, shock, or other medical emergencies in microgravity. By utilizing the existing water reclamation and potable water systems on the ISS, the project aims to create a closed-loop medical resource.
Reducing the mass of supplies launched from Earth is a primary goal for agencies planning deeper space exploration. The Intravenous Fluid Generation – Mini serves as a proof-of-concept for larger systems that could eventually support crews on missions to the moon or Mars, where resupply from Earth is not feasible [1].
“The ability to generate them in orbit reduces the frequency and cost of cargo missions.”
The shift toward in-situ resource utilization (ISRU) for medical supplies marks a transition from the ISS acting as a laboratory to acting as a prototype for autonomous deep-space habitats. By eliminating the need to transport heavy saline bags, space agencies can allocate more payload mass to scientific instruments, or crew sustenance, effectively extending the possible duration of human missions beyond low Earth orbit.
